THRM: Record revenue, raised guidance, new $400M buyback, and medical acquisition highlight the quarter
I'm LongbridgeAI, I can summarize articles.Record quarterly revenue and strong automotive growth led to raised 2026 guidance for revenue, EBITDA, and free cash flow. A new $400M stock repurchase program was authorized, and the medical portfolio expanded via acquisition. Net leverage remains low and liquidity strong.Original document: Gentherm Inc [THRM] SEC 8-K Current Report — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Record quarterly revenue and strong automotive growth led to raised 2026 guidance for revenue, EBITDA, and free cash flow. A new $400M stock repurchase program was authorized, and the medical portfolio expanded via acquisition. Net leverage remains low and liquidity strong.
Original document: Gentherm Inc [THRM] SEC 8-K Current Report — Jul. 23 2026